About this trial
Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adults (older than 18 years of age)
both sexes
primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons
if the patients had a bilateral pterygium, only one eye will be operated
Disqualifiers
connective tissue disease
prior eye surgery
chronic use of topical drugs (anti-glaucoma drugs)
Trial design
Parallel
Treatments tested in this trial
Cauterization
Procedure/SurgeryTo ensure the stability of the graft during cuttings, four sealing wraps will be installed, which will be removed after cauterisation is completed. Autograft and conjunctiva will be approximated by surgical forceps and will be cauterized using a bipolar cutter (Erbe ICC 50) with a force 1-3 / 20. Forceps will be released slowly to prevent elevation of the graft. The same procedure will be performed 10 times until graft is well firmed. Graft stability will be checked up with a sponge and additional cauterization will be preformed if needed.
Fibrin glue
Procedure/SurgeryFiber adhesive (Tissel 1 mL kit4-iu) will be prepared according to manufacturer's instructions. Preparation time will be approximately 10-15 min per kit. Once mixed the fibrin glue is usable up to 4 h. For the purpose of the study preparation of the fibrin glue will be performed by a nurse.
Treatment groups
Trial outcomes
Primary outcomes
Recurrence of pterygium
Any re-growth of tissue from the area of excision across the limbus onto the cornea.
Secondary outcomes
Surgical time
Surgical time: total operational time required for completion of the operation (measured in minutes)
Complication rate
Complication rate will be analyzed as the occurrence of at least one of the following major complications such as dehiscence, displacement or loss of the autograft, infection, haemorrhage, oedema, fibrosis, retraction and other indications that required special treatment
Pterygium-induced astigmatism
Measured as described by Hsu 2014
Ocular surface condition
The Ocular Surface Disease Index (OSDI) is a 12-question validated questionnaire used to measure ocular symptoms, visual function, and environmental factors that may affect a patient's vision. The OSDI scoring scale ranges from 0 to 100. The lower the score, the more symptomatic relief from dry eye symptoms a patient experiences. Baseline-adjusted scores were tabulated; a negative number change from baseline indicates a perceived improvement in ocular comfort.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Split, School of Medicine
Lead sponsor
University Hospital of Split
Collaborator